• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 464477 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418995885 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418995885 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Acadia Pharmaceuticals Rise Above Previous 52-Week High

Published on Thu, 03/21/2013 - 14:10
By Mallory Stone

Shares of Acadia Pharmaceuticals (NASDAQ:ACAD) traded today at $8.70, breaking its 52-week high. So far today approximately 18.6 million shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.

In the past 52 weeks, Acadia Pharmaceuticals share prices have been bracketed by a low of $1.29 and a high of $8.70 and are now at $8.67, 572% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 2.3% while the 50-day MA has advanced 1.6%.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Acadia Pharmaceuticals (NASDAQ:ACAD) is currently priced 3.1% above its average consensus analyst price target of $8.40. The stock should find initial support at its 50-day moving average (MA) of $6.02 and further support at its 200-day MA of $3.35.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Ventas had the Lowest Relative Performan...

Here are 5 stocks in the Specialized REITs industry ranked by performance. We compiled ...

Bottom 5 Companies in the Specialized Fi...

Here are 5 stocks in the Specialized Finance industry ranked by performance. We compil ...

Short-term Underperformance Detected in ...

Below are five companies in the Semiconductors industry that underperformed yesterday o ...

Shares of FormFactor Underperformed its ...

Here are 5 stocks in the Semiconductor Equipment industry ranked by performance. We co ...

Bottom 5 Companies in the Retail REITs I...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...

Bottom 5 Companies in the Restaurants In...

Below are five companies in the Restaurants industry that underperformed yesterday on a ...

Analysis of Relative Performance in the ...

Below are five companies in the Residential REITs industry that underperformed yesterda ...

Short-term Underperformance Detected in ...

Analysis was conducted on the Reinsurance industry to measure relative performance to f ...